Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05899348 · ClinicalTrials.gov registry record · NA

iTEST: Introspective Accuracy as a Novel Target for Functioning in Psychotic Disorders

A NA study, sponsored by University of California, San Diego.

Completed
Registry status
NA
Development phase
69
Enrollment target

NCT05899348 is a NA study that has completed, run by University of California, San Diego. The registered enrollment target is 69 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05899348, a NA study, has completed, sponsored by University of California, San Diego.

COMPLETED
Registry status
NA
Development phase
69 participants
Enrollment target

Study Summary

People with psychotic disorders experience a high level of functional disability, and a major contributor to this disability is introspective accuracy, which is defined as inaccurate judgements of one's abilities and performance on tasks. Yet, no intervention has directly targeted introspective accuracy for psychotic illnesses. This trial will evaluate a new intervention, called iTEST, that uses mobile devices to train people with psychotic disorders to improve introspective accuracy and, ultimately, functional outcomes

Interventions

  • BEHAVIORAL iTEST

Trial Details

FieldValue
Enrollment Target 69 participants
Start Date 2023-10-01
Est. Completion 2025-08-01
Phase NA

Sponsor

University of California, San Diego

775 total trials

What the Registry Record Tells You About NCT05899348

The ClinicalTrials.gov registry entry for NCT05899348 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 69 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which iTEST is the first listed.

NCT05899348 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05899348 about?

NCT05899348 is a clinical study titled "iTEST: Introspective Accuracy as a Novel Target for Functioning in Psychotic Disorders". People with psychotic disorders experience a high level of functional disability, and a major contributor to this disability is introspective accuracy, which is defined as inaccurate judgements of one's abilities and performance on tasks. Yet, no intervention has directly targeted introspective accu...

What is the current status of trial NCT05899348?

This trial is currently completed. It is a NA study. The enrollment target is 69 participants. The study started on 2023-10-01. Estimated completion is 2025-08-01.

What interventions are being tested in trial NCT05899348?

The interventions under investigation include: iTEST (BEHAVIORAL).

Who is sponsoring clinical trial NCT05899348?

This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.